| Metric | შპს არტ ფარმა | შპს ფარმა სთორი | შპს საფ ფარმა | შპს Europharma Georgia ევროფარმა ჯორჯია | შპს გოლდ ფარმა |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue | ₾6.2m₾5.7m | ₾6.3m₾5.4m | ₾6.4m₾6.5m | ₾6.4m₾5.4m | ₾6.5m₾8.1m |
| Revenue growth | 10.0% | 15.1% | -1.3% | 19.8% | -19.1% |
| Profitability | |||||
| EBITDA | ₾2.0m₾2.1m | ₾828k₾524k | ₾1.4m₾1.2m | ₾651k₾577k | ₾2.5m₾3.6m |
| EBITDA margin | 31.4%36.9% | 13.2%9.6% | 22.5%18.4% | 10.2%10.8% | 38.8%44.2% |
| Net profit | ₾2.0m₾2.1m | ₾815k₾515k | ₾1.5m₾1.1m | ₾643k₾577k | ₾3.9m₾3.6m |
| Net margin | 31.4%36.8% | 13.0%9.5% | 23.0%17.7% | 10.0%10.8% | 60.5%44.2% |
| Balance sheet | |||||
| Total assets | ₾13.7m₾9.8m | ₾5.9m₾4.4m | ₾5.3m₾5.4m | ₾5.1m₾4.9m | ₾48.5m₾40.1m |
| Total equity | ₾11.4m₾9.4m | ₾3.2m₾2.4m | ₾2.7m₾1.2m | ₾3.1m₾2.2m | ₾26.5m₾22.6m |
| ROE | 17.2%22.2% | 25.7%21.9% | 54.6%93.9% | 20.6%26.4% | 14.8%15.8% |